Company intelligence / Profile preview

BioVendor

Ownership: Private
Development stage: Commercial

Overview

BioVendor is an international group of biotechnology companies specializing in the development, production, and distribution of immunoassays, recombinant proteins, antibodies, and endotoxin-removal products for research and clinical diagnostics. Their portfolio supports predictive and personalized medicine through high-quality IVD solutions.

Modalities: AntibodyRecombinant proteinImmunoassay
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on BioVendor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioVendor.

Explore the full profile